Gene Details: GNE


1 / 1

General Information

Gene Name: GNE (Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase)
Synonym: GLCNE
Short Names:
Alternative Names: UDP-GlcNAc-2-epimerase/ManAc kinase;

Notes:


Description from Dr.Glyco-GPT:

Write a 100-350 word essay about the enzyme human GNE. Provide information related to enzyme: i) function, ii) reaction pathways, ii) Location, and iv) diseases. In writing include these four subheadings

### Function
Human GNE, or glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase, is a bifunctional enzyme that plays a critical role in the biosynthesis of sialic acids. GNE catalyzes the first two steps in this pathway: it converts UDP-N-acetylglucosamine (UDP-GlcNAc) to N-acetylmannosamine (ManNAc) through its epimerase activity and then phosphorylates ManNAc to produce ManNAc-6-phosphate through its kinase activity. Sialic acids, the end products of this pathway, are essential for cellular functions, including cell-cell interactions, immune response, and protein stability.

### Reaction Pathways
GNE is central to the sialic acid biosynthesis pathway. The enzyme first epimerizes UDP-GlcNAc to produce ManNAc, which is subsequently phosphorylated to ManNAc-6-phosphate. This molecule is then further converted to N-acetylneuraminic acid (Neu5Ac), the most common form of sialic acid. Sialic acids are then activated to CMP-sialic acid, which is used in the glycosylation of proteins and lipids, forming sialoglycoconjugates that are crucial for many biological processes, including the regulation of immune responses and cell signaling.

### Location
GNE is predominantly localized in the cytoplasm, where it interacts with its substrates to initiate the sialic acid biosynthesis pathway. The cytoplasmic localization allows GNE to efficiently catalyze the early steps of sialic acid production, ensuring a steady supply of this important molecule for glycosylation processes in the Golgi apparatus and other cellular compartments.

### Diseases
Mutations in the GNE gene are associated with a rare neuromuscular disorder known as GNE myopathy, also known as hereditary inclusion body myopathy (HIBM). This condition is characterized by progressive muscle weakness and atrophy, particularly in the distal muscles. The disease results from impaired sialic acid biosynthesis due to defective GNE enzyme activity, leading to reduced sialylation of glycoproteins, which affects muscle function. In addition to GNE myopathy, altered GNE activity has been implicated in other disorders related to sialic acid metabolism, highlighting the enzyme’s critical role in maintaining cellular and systemic homeostasis.

Catalytic Activity

Reaction Image

Reaction and Disease Links

EC # (IUBMB): 3.2.1.183 2.7.1.60
Brenda: 2.7.1.60 3.2.1.183 5.1.3.14
OMIM: 269921 600737 603824 605820
KEGG: 10020
Rhea: 30683 23832
Reactome : R-HSA-4085001 R-HSA-4085011

Transcript levels (Cell lines and Single cell data) URL


CRISPR-knockout

CRISPR-activation

CRISPR-inactivation


Top 10 TFs

TF Score
TCF25 0.349006
SSU72 0.337340
UBE2I 0.335501
YY1 0.332398
NCOR1 0.331547
SNRNP70 0.330938
ZNF207 0.325469
BCLAF1 0.324426
HNRNPH1 0.323872
SON 0.323490


Licensing: CC BY 4.0. You are fee to copy, redistribute, remix, transform and build upon this material for commercial and non-commercial purposes, provided source of information is attributed/credited.